Leptin in non-autoimmune inflammation

review OA: closed public-domain-us
View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This review examines leptin's role in non-autoimmune inflammatory diseases including renal, liver, lung, atherosclerosis, metabolic syndrome, Behçet's disease, and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Leptin is an adipokine that modulates multiple functions including energy homeostasis, thermoregulation, bone metabolism, endocrine and pro-inflammatory immune responses. Several studies have implicated leptin in the pathogenesis of chronic autoimmune inflammatory conditions such as autoimmune encephalomyelitis, intestinal bowel inflammation and type-1 diabetes. This review focuses on the role of leptin in non-autoimmune inflammatory diseases that include renal, liver and lung inflammation, atherosclerosis and metabolic syndrome, Behçet's disease and endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Leptin Leptin Metabolic Diseases Recombinant Proteins Recombinant Proteins Animals Humans Inflammation Leptin Leptin Leptin Lipid Metabolism Metabolic Diseases Metabolic Diseases Metabolic Diseases Metabolic Diseases Oxidative Stress Recombinant Proteins Recombinant Proteins Recombinant Proteins

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-20T06:19:39.675353+00:00
pubmed
last seen: 2026-05-13T22:13:59.677786+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine